Cholecalciferol Supplementation Induced Up-Regulation of


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
08 06 2023
Historique:
received: 10 05 2023
revised: 05 06 2023
accepted: 06 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Multiple sclerosis is a common immune-mediated inflammatory and demyelinating disease. Lower cholecalciferol levels are an established environmental risk factor in multiple sclerosis. Although cholecalciferol supplementation in multiple sclerosis is widely accepted, optimal serum levels are still debated. Moreover, how cholecalciferol affects pathogenic disease mechanisms is still unclear. In the present study, we enrolled 65 relapsing-remitting multiple sclerosis patients who were double-blindly divided into two groups with low and high cholecalciferol supplementation, respectively. In addition to clinical and environmental parameters, we obtained peripheral blood mononuclear cells to analyze DNA, RNA, and miRNA molecules. Importantly, we investigated miRNA-155-5p, a previously published pro-inflammatory miRNA in multiple sclerosis known to be correlated to cholecalciferol levels. Our results show a decrease in miR-155-5p expression after cholecalciferol supplementation in both dosage groups, consistent with previous observations. Subsequent genotyping, gene expression, and eQTL analyses reveal correlations between miR-155-5p and the

Identifiants

pubmed: 37372417
pii: genes14061237
doi: 10.3390/genes14061237
pmc: PMC10297972
pii:
doi:

Substances chimiques

Cholecalciferol 1C6V77QF41
MicroRNAs 0
MIRN155 microRNA, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Hum Genet. 2020 Mar 5;106(3):327-337
pubmed: 32059762
Cell Mol Neurobiol. 2023 Mar;43(2):455-467
pubmed: 35107690
Biomed Rep. 2015 Jan;3(1):98-104
pubmed: 25469256
Neurol Res. 2022 Mar;44(3):217-223
pubmed: 34503396
BMC Bioinformatics. 2011 Jul 26;12:300
pubmed: 21791068
J Exp Med. 2014 Mar 10;211(3):545-61
pubmed: 24590764
Exp Cell Res. 2023 Mar 1;424(1):113490
pubmed: 36706943
Z Gastroenterol. 2019 Oct;57(10):1218-1225
pubmed: 31610585
Int J Mol Sci. 2021 Apr 21;22(9):
pubmed: 33919306
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):334-7
pubmed: 20298782
Mult Scler. 2013 Dec;19(14):1849-57
pubmed: 23773985
Neurology. 2011 Feb 8;76(6):540-8
pubmed: 21300969
J Clin Med. 2019 Jan 14;8(1):
pubmed: 30646527
Genome Res. 2014 Jun;24(6):989-98
pubmed: 24803592
J Immunol. 2013 Apr 1;190(7):3687-95
pubmed: 23436936
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1193-1200
pubmed: 31217172
Neurology. 2012 Nov 20;79(21):2140-5
pubmed: 23170011
Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):901-21
pubmed: 23917093
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
J Exp Med. 2011 Apr 11;208(4):823-39
pubmed: 21464221
J Clin Invest. 2012 Apr;122(4):1180-8
pubmed: 22466660
Adv Exp Med Biol. 2017;1024:111-131
pubmed: 28921467
Neurology. 2011 Apr 19;76(16):1410-4
pubmed: 21502600
Biochem Genet. 2021 Feb;59(1):1-30
pubmed: 33159645
PLoS Med. 2015 Aug 25;12(8):e1001866
pubmed: 26305103
Nat Protoc. 2010 Sep;5(9):1564-73
pubmed: 21085122
Neurol Clin. 2011 May;29(2):207-17
pubmed: 21439437
PLoS One. 2018 Oct 18;13(10):e0206239
pubmed: 30335862
Int J Mol Sci. 2011;12(12):8695-712
pubmed: 22272099
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:81-6
pubmed: 24103701
BMC Neurol. 2022 Nov 3;22(1):405
pubmed: 36329419
Nature. 2018 Jan 25;553(7689):530
pubmed: 29258290
PLoS One. 2009 Oct 13;4(10):e7440
pubmed: 19823682
Osteoporos Int. 2009 Nov;20(11):1807-20
pubmed: 19543765
FASEB J. 2014 Jun;28(6):2551-65
pubmed: 24604078
J Cell Biol. 2021 Dec 6;220(12):
pubmed: 34705029
Allergol Immunopathol (Madr). 2023 Mar 01;51(2):115-119
pubmed: 36916095
F1000Res. 2018 Mar 2;7:260
pubmed: 29568499
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9
pubmed: 17242365
Iran J Microbiol. 2022 Aug;14(4):495-502
pubmed: 36721512
Nat Rev Immunol. 2005 Jun;5(6):472-84
pubmed: 15928679

Auteurs

Saša Gselman (S)

Clinic of Neurology, University Clinical Centre Maribor, 2000 Maribor, Slovenia.

Tanja Hojs Fabjan (TH)

Clinic of Neurology, University Clinical Centre Maribor, 2000 Maribor, Slovenia.
Department of Neurology, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.

Anja Bizjak (A)

Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.

Uroš Potočnik (U)

Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.
Laboratory of Biochemistry, Molecular Biology and Genomics, Faculty of Chemistry and Chemical Engineering, University of Maribor, 2000 Maribor, Slovenia.
Department for Science and Research, University Clinical Centre Maribor, 2000 Maribor, Slovenia.

Mario Gorenjak (M)

Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH